Evidence map›Paper›PMID 41555836›Full record

ArticleDiabetes, obesity & metabolism2026

Association between daily steps, diabetes management and health indicators in people living with type 1 diabetes: A cross-sectional study from the BETTER registry.

Thélo I Garré, Capucine G Guédet, Laure Alexandre-Heymann, Virginie Messier, Valérie Boudreau, Semah Tagougui, Claude Laforest, Anne-Sophie Brazeau, Rémi Rabasa-Lhoret, Jane E Yardley

Abstract read
In one paragraph

Article in Diabetes, obesity & metabolism, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Thélo I GarréMontréal Clinical Research Institute (IRCM), Montréal, Québec, Canada.
Capucine G GuédetMontréal Clinical Research Institute (IRCM), Montréal, Québec, Canada.
Laure Alexandre-HeymannMontréal Clinical Research Institute (IRCM), Montréal, Québec, Canada.
Virginie MessierMontréal Clinical Research Institute (IRCM), Montréal, Québec, Canada.
Valérie BoudreauMontréal Clinical Research Institute (IRCM), Montréal, Québec, Canada.
Semah TagouguiUniversité de Lille, Université d'Artois, Université du Littoral Côte d'Opale, ULR 7369 - URePSSS - Unité de Recherche Pluridisciplinaire Sport, Santé, Société (URePSSS), Lille, France.ORCID 0000-0002-6761-2648
Claude LaforestPatient Partner Affiliated with Montréal Clinical Research Institute (IRCM), Montréal, Québec, Canada.
Anne-Sophie BrazeauMontréal Clinical Research Institute (IRCM), Montréal, Québec, Canada.ORCID 0000-0002-2699-2920
Rémi Rabasa-LhoretMontréal Clinical Research Institute (IRCM), Montréal, Québec, Canada.ORCID 0000-0003-4706-5170
Jane E YardleyMontréal Clinical Research Institute (IRCM), Montréal, Québec, Canada.ORCID 0000-0001-8761-7019

Funding

Breakthrough T1D 4-SRA-2018-651-Q-RDexcomDiabète QuébecEli Lilly and CompanyMila and Brian Mulroney Research Chair in DiabetesNovo Nordisk CanadaSanofiStrategy for Patient-Oriented Research JT1-157204
6 · The paper itself

Abstract

aimsIn people with type 1 diabetes, physical activity provides important health benefits but is mainly limited by fear of hypoglycaemia. Daily step count is a simple indicator of ambulatory activity. This study examined associations between step count and health indicators. MATERIALS AND

methodsAdults from the Behaviours, Therapies, Technologies and Hypoglycaemic Risk in Type 1 Diabetes registry wore a validated pedometer (PiezoRxD®) for 7-12 days and were classified based on mean daily steps: <7000 (group 1), 7000-10 000 (group 2), and >10 000 (group 3). Between-group comparisons used analysis of variance and chi-square/Fisher's tests with Bonferroni correction. Multivariable models adjusted for potential confounders.

resultsA total of 383 participants (333 T1D, 50 latent autoimmune diabetes) were included (group 1: 163; group 2: 125; group 3: 95). Mean age was 46.7 ± 13.3 years, 63% were women, diabetes duration was 24.2 ± 15.6 years, and body mass index (BMI) 26.1 ± 4.5 kg/m

conclusionsAmong adults living with type 1 diabetes, higher daily step counts were associated with more favourable glycaemic and anthropometric profiles, as well as lower use of depression/anxiety medication without evidence of increased hypoglycaemia. Causality cannot be inferred, and reverse causation is possible.

Indexed as

Diabetes Mellitus, Type 1ExerciseAdultBody Mass IndexCross-Sectional StudiesFemaleGlycated HemoglobinHumansHypoglycemiaHypoglycemic AgentsMaleMiddle AgedRegistriesGlycated HemoglobinHypoglycemic Agentspatient reported outcomespopulation studyreal‐world evidencetype 1 diabetes

Identifiers

PMID41555836
PMCPMC12992167

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.